Clinical Trials Browser

Phase 3 × Head and Neck Neoplasms × Lapatinib × Clear all

NCT00424255 2014-07-18

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Phase 3 Completed

688 enrolled 19 charts

Head and Neck Neoplasms